NewsStudy result: Do Biontech and Moderna have the same...

Study result: Do Biontech and Moderna have the same side effects as AstraZeneca?

A study from the UK provides new insights into cerebral vein thrombosis associated with mRNA vaccines from Biontech and Moderna.

First report from April 20: The AstraZeneca vaccine had repeatedly made negative headlines in the past few weeks. The vaccine had produced very severe side effects in several cases after vaccination. Numerous cerebral vein thromboses have been reported, in some cases even fatal. At first it was unclear whether there was a connection with the AstraZeneca vaccine. Several countries then stopped vaccinations. Then researchers found the reason for the severe side effects *.

Study from Great Britain: New study on cerebral vein thrombosis in vaccinated people

After all the incidents, the Standing Vaccination Commission (STIKO) recommended that the vaccine only be vaccinated in over 60-year-olds *, reported *. The background: Previously, the vaccine was only injected to under 65-year-olds. However, the cerebral vein thrombosis was found very often in young women. But what about the popular vaccines from Biontech / Pfizer and Moderna? Are there no thromboses with these vaccines?

British researchers are now claiming: cerebral vein thrombosis is just as common with Biontech and Moderna as with AstraZeneca. A study from Oxford University looked into the frequency of blood clots in the brain and liver related to Covid-19 and vaccinations against the coronavirus. The researchers came to a shocking result: After a Covid-19 vaccination, the risk of a blood clot in the brain is about ten times higher than under normal circumstances. And that applies not only to the vector vaccine by AstraZeneca, but also for mRNA vaccines BioNTech and Moderna reported

British study: risk of cerebral vein thrombosis just as high with Biontech and Moderna?

The researchers at Oxford University compared risks for particular types of blood clots in the study. Like the one for Covid-19 sufferers, for those with the mRNA preparations and for those with the vector vaccine from AstraZeneca. For this purpose, all data from the USA and Europe were included. The result: The risk of cerebral vein thrombosis for vaccinated people was higher than normal. However, there were hardly any differences between the different vaccines:

Manufacturer: Vaccine: Cases per 1 million vaccinated
Biontech / Pfizer & Moderna mRNA vaccine 4 cases
AstraZeneca Vector vaccine 5 cases

However, the Oxford University study only refers to cerebral vein and portal vein thrombosis. However, another phenomenon plays a very important role in the side effects of AstraZeneca: thrombocytopenia – a lack of blood platelets. The two very rarely occurred together, but when they did it was fatal in most cases. However, the Oxford scientists will not investigate the risk of both thrombosis and thrombocytopenia associated with the vaccinations.

Cerebral vein thrombosis after Covid-19 vaccination: There have been so many cases in Germany so far, according to PEI

According to the Paul Ehrlich Institute (PEI), there have been 89 cases of thrombosis in Germany after vaccination with the vaccine from Biontech / Pfizer. The same applies to Moderna. Cerebral vein thrombosis occurred in seven cases. No thrombocytopenia was found in any of the cases. It was different with AstraZeneca. The combination occurred in 27 cases. In 23 cases it was a dangerous cerebral vein thrombosis. Eight people died, five of them women and three men.

Similar observations were made with the Johnson & Johnson vector vaccine as with AstraZeneca. Cerebral vein thrombosis occurred in six cases, and thrombocytopenia also occurred in three of them. Authorities then recommended suspending vaccinations.

New study on Covid-19 vaccinations: amazing findings on the risks of cerebral vein thrombosis

Nevertheless, the results of the British study should be viewed with caution due to the different data sources, the researchers themselves emphasize. Nevertheless, there is another important finding from the study: With Covid 19, the risk of a cerebral vein thrombosis is about 100 times higher as usual. 30 percent of the cases occur in people under 30 years of age. With the Covid-19 vaccines there is just an 8-10 times higher risk.

The University of Oxford worked with AstraZeneca to develop the vaccine against Covid-19. So far, however, there are no indications of a conflict of interest, so that one can assume that the university is trying to put AstraZeneca’s risks into perspective. According to the scientists who submitted the data, the team worked on the study independently of the university’s vaccine team. * is an offer from IPPEN.MEDIA.

List of rubric lists: © Michael Reichel / dpa

To swim with sharks! This is how entrepreneurs float in the face of inflation

The most successful entrepreneur, and the one who can swim and fall in love with sharks, is the one who is willing to learn from every moment of his process, points out Luis Arandia.

#Between the lines | COVID-19. The sixth wave is coming and a (new) variant...

It is not possible to declare when the sixth wave will arrive in Mexico, but now, more than ever, it is urgent that virological surveillance be maintained, points out Jonathán Torres.

In the new reality, brands must establish messages of closeness

The diffusion of modifications to the organizational culture in the face of a new scenario will be successful if it is underpinned by transparent, close and reliable communication, considers Mario Maraboto.

Covid-19: The end of the pandemic is in sight, says the WHO

Tedros Adhanom Ghebreyesus highlighted that last week the number of weekly deaths fell to its lowest level since March 2020.

#Between the lines | The (yet) unsolved mystery of COVID-19

Suddenly it seems that there is a battle between specialists from different medical specialties to see who announces the next misfortune, says Jonathán Torres.